| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Peter L Rhein last filed a Form 4 in February 2025, as Director at DOC. The filings on record cover 2 companies. Peter L Rhein's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 19,821 shares of CNS. The CNS filings lean toward selling, a net 2,500 shares.
Peter L Rhein has 35 Form 4 filings on record from April 2015 to February 2025, across 2 companies: Director at Cohen & Steers (CNS), 2019–2025; Director at Healthpeak Properties (DOC), 2015–2018.
The 40 reported transactions were 29 stock awards, 7 gifts, 3 open-market sales and 1 plan transaction.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $468K.
The largest open-market sale was 2,500 shares of CNS at an average $105.51 on October 18, 2024, about $264K. Twelve months later CNS was down 35%.
Shares as reported in the last Form 4 for each company; the most recent is from February 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.